Correlation Between Seer and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Seer and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Neurocrine Biosciences, you can compare the effects of market volatilities on Seer and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Neurocrine Biosciences.
Diversification Opportunities for Seer and Neurocrine Biosciences
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Seer and Neurocrine is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Seer i.e., Seer and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Seer and Neurocrine Biosciences
Given the investment horizon of 90 days Seer Inc is expected to under-perform the Neurocrine Biosciences. In addition to that, Seer is 2.41 times more volatile than Neurocrine Biosciences. It trades about -0.01 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.04 per unit of volatility. If you would invest 10,829 in Neurocrine Biosciences on October 21, 2024 and sell it today you would earn a total of 3,497 from holding Neurocrine Biosciences or generate 32.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Seer Inc vs. Neurocrine Biosciences
Performance |
Timeline |
Seer Inc |
Neurocrine Biosciences |
Seer and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seer and Neurocrine Biosciences
The main advantage of trading using opposite Seer and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |